



Per capita income: $9,880
Life expectancy at birth: W 67/M 62 yrs
Infant mortality rate: 39/1000 live births
TOP 10 CAUSES OF DEATH
1. HIV/AIDS
2. Lower Respiratory Infections
3. Ischemic Heart Disease
4. TB







  7  U.S. Assignees
31  Locally Employed
  4  Contractors 
   1  Fellow 
In line with the PEPFAR mission, the goal of all support to the MoHSS is 
to ensure that Namibia will soon have an AIDS-free generation as defined 
in Namibia’s National Strategic Framework for HIV and AIDS Response 
(NSF) and in accordance with the UNAIDS 90-90-90 goals for ending the 
HIV/AIDS epidemic by 2030. In line with this framework, CDC-Namibia 
supports a comprehensive portfolio of HIV/AIDS prevention, care, 
treatment, strategic information, and systems strengthening programs to 
the national public health sector.
HIV/AIDS 
Namibia has one of the world’s highest HIV prevalence rates. The 2013 
Demographic and Health Survey reported a national adult population 
prevalence of 14% and as high as 23.7% in one of the regions. There is a 
disproportionate distribution of prevalence between women (16.9%) and 
men (10.9%) aged 15-49. There are an estimated 217,000 people living 
with HIV in Namibia, and 166,000 (76%) of those individuals are receiving 
antiretroviral therapy. 
Source: Population Reference Bureau 2015: Namibia
Source: WHO Country Health Profiles 2015-Namibia
Since 2002 CDC-Namibia has assisted the Namibian Ministry of Health and Social Services (MoHSS) in 
developing and implementing an integrated comprehensive package of HIV/AIDS prevention, care, and 
treatment programs. CDC-Namibia provides targeted technical assistance and funding support to the MoHSS 
and several implementing partners, building the capacity of Namibia’s healthcare workforce to lead and 
manage its HIV program more effectively. Technical assistance has strengthened national efforts to prevent the 
sexual and biomedical transmission of HIV and to expand care and treatment services, including the prevention 
of mother-to-child transmission (PMTCT). 
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Prevention
CDC provides technical assistance to the MoHSS and partners to 
implement evidence-based prevention activities including PMTCT, 
voluntary medical male circumcision, ARV-based HIV prevention 
interventions (ART, PEP and PrEP), and HIV counseling and testing. 
Key achievements and activities include:
 • Previously, approximately 30% of babies born to HIV positive 
mothers were being infected with HIV. Today less than 5% of babies 
born to HIV positive mothers become infected. 
 • CDC is supporting efforts to reach men through the piloting of 
multi-disease screening outreach initiatives. 
 • CDC is planning for the roll out of HIV and gender based violence 
risk reduction activities in two districts with the intention of 
targeting nearly 20,000 young girls aged 10-24.
Care and treatment
Through PEPFAR support, CDC provides technical assistance for the 
continuum of care to infected and affected adults and children via 
health facilities and community-based organizations. Namibia has 
adopted the WHO 2016 antiretroviral therapy guidelines. The initiation 
of treatment regardless of CD4 count or clinical stage will improve 
the survival rate of people living with HIV/AIDS and decrease HIV 
transmission to HIV un-infected partners. 
Key achievements and activities include:
 • Support to the MoHSS to roll out over 50 community-based  
ART clinics.  
 • More than 85% of patients on treatment have access to viral load 
testing and more than 87% of patients on treatment are virally 
suppressed. 
 • More than 90% of patient on treatment are retained. This has been  
achieved through intensive patient support including tracing 
patients lost to follow up. 
In 2017, Namibia launched the Namibia Population-based HIV Impact 
Assessment Survey (NAMPHIA). The goal of the survey is to examine 
the current distribution of  the HIV epidemic and assess the impact of 
Namibia’s prevention, care and treatment response across all 14 regions 
of Namibia. The survey is funded by PEPFAR through CDC. 
Tuberculosis Activities
CDC also supports comprehensive TB/HIV activities in Namibia, 
including improving and integrating TB and HIV services for coinfected 
individuals, providing isoniazid preventative therapy for all eligible 
HIV-positive individuals, and supporting TB infection control efforts 
in healthcare facilities. CDC is also providing technical assistance 
for Namibia’s first national TB disease prevalence survey, which will 
measure TB prevalence using a population-based survey.
IMPACT IN NAMIBIA
97% of HIV-positive women during 
antenatal care received antiretroviral 
therapy for prevention of mother-to-
child transmission of HIV. 
Antiretroviral therapy provided to 68% 
of adults and >90% of children in need
97% of HIV positive patients screened 
for TB in HIV care and treatment 
settings 100% of blood donations 
screened for HIV
National laboratory networks 
supported enabling improved disease 
detection and response
As of 2015, Namibia’s TB treatment 
success rate is 85%.
The proportion of people in Namibia 
who are diagnosed with active TB 
disease who also know their HIV status 
increased from 30% to >95% between 
2006 and 2016.
For more country information 
www.cdc.gov/globalhealth/countries/namibia
